| LINE ITEM (USD / %) | FY 2025
FILED 2025-08-31 | FY 2024
FILED 2024-08-31 | FY 2023
FILED 2023-08-31 |
|---|---|---|---|
| Revenue (Total Sales) | $620.0M | $590.6M | $537.3M |
| YoY Revenue Growth % | +5.0% | +9.9% | — |
| Gross Profit | $341.3M | $315.2M | — |
| Gross Margin % | 55.1% | 53.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $103.8M | $96.4M | $89.7M |
| Operating Margin % | 16.7% | 16.3% | 16.7% |
| Net Income (GAAP) | $91.0M | $69.6M | $66.0M |
| EBITDA (Normalized) | $107.4M | $99.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $87.9M | $92.0M | $98.4M |
| Capital Expenditures (CapEx) | $4.5M | $4.2M | — |
| Free Cash Flow (FCF) | $83.4M | $87.8M | $98.4M |
| FCF Margin % | 13.5% | 14.9% | 18.3% |
| Return on Invested Capital (ROIC %) | 27.2% | 29.7% | — |
| Cash & Short-Term Equivalents | $48.6M | $54.9M | — |
| Total Debt (Short + Long Term) | $85.7M | $84.6M | — |
| Total Stockholders' Equity | $264.1M | $226.3M | — |